GlassScriptPhysician profile
Keith L Stanley
NPI 1992773188
$1,053.42
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
See the full distribution for Sports Medicine (Family Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $550 · 2020: $205 · 2021: $196 · 2022: $103.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Therapeutics, INC. | $445.31 | 2019-2021 | |
| Bioventus LLC | $141.46 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $127.22 | 2019-2022 | |
| Ferring Pharmaceuticals INC. | $111.90 | 2019 | |
| Horizon Therapeutics Plc | $69.98 | 2019-2022 | |
| Pacira Pharmaceuticals Incorporated | $68.81 | 2021-2022 | |
| Stryker Corporation | $30.96 | 2019 | |
| Depuy Synthes Sales INC. | $23.08 | 2019 | |
| Pylant Medical | $18.09 | 2019 | |
| Zyla Life Sciences, INC. | $16.61 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keith Stanley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.